Fund HoldingsForesite Capital Management V, LLC

Total Portfolio Value
$271.00M
Total Bought
$103.67M
Total Sold
$18.23M
Net Transaction
+$85.44M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
ALUMIS INC.5,779,3485,896,995+117,64756,406129,91147.94%+73,504
CG Oncology, Inc.(CGON)1,004,0501,004,050041,68867,95425.08%+26,266
Eikon Therapeutics, Inc.01,318,983+1,318,983013,9555.15%+13,955
Hims & Hers Health, Inc.(HIMS)273,151738,151+465,0008,86915,3245.65%+6,455
Pharvaris N.V.
COM
0194,125+194,12505,4842.02%+5,484
Nurix Therapeutics, Inc.(NRIX)0265,000+265,00004,1081.52%+4,108
Disc Medicine, Inc.(IRON)299,069374,069+75,00023,74923,9188.83%+169
Maze Therapeutics, Inc.(MAZE)86,29125,905-60,3863,5757730.29%-2,802
Lyell Immunopharma, Inc.477,078477,078014,6849,5703.53%-5,114
Natera, Inc.(NTRA)67,3560-67,35615,4310-15,431
Page 1 of 1